Abstract
The occurrence of cancer of the breast has long been known [1–4] and the disease affects women of all races and nationalities and the incidence of has increased 30–40 % since the 1970s [2, 4–7]. This already dismal picture is worsened by the gradual increase in breast cancer incidence in most Western countries and in societies that recently became westernized or that are in the process of westernization [8, 9]. Epidemiological observations that daughters of women who migrate from low-incidence to high-incidence countries acquire the breast cancer risk prevailing in the new country [10], suggest that aspects of lifestyle or the environment are major determinants of breast cancer risk. A study of population-attributable risks has estimated that at least 45 % to 55 % of breast cancer cases in the United States may be explained by the following factors: advanced age at the time of the first full-term pregnancy, nulliparity, family history of breast cancer, higher socioeconomic status, earlier age at menarche, and prior benign breast disease [11]. Other statistical models appear to explain an even higher proportion of breast cancer on the basis of known risk factors [12]. Studies of atomic bomb survivors have shown that environmental exposures, such as ionizing radiation, are a risk factor for breast cancer [13]. Exposure to radiation at a young age (Fig. 1.1) has been identified as a causative agent of breast cancer in selected populations [14–17], but there is no definitive proof of what causes breast cancer in the population at large. The increased risk associated with exposure to environmental chemicals, such as alcohol [18] and cigarette smoke [19–25], makes these agents suspects for causing cancer in the human population (Fig. 1.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Breasted JH (ed) (1991) The Edwin Smith Surgical Papyrus: published in facsimile and hieroglyphic transliteration with translation and commentary in two volumes, vol 1. University of Chicago Press, Chicago
Clarke CA, Purdie DM, Glaser SL (2006) Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer 6:170
Botha JL, Bray F, Sanlika R, Parkin DM (2003) Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39:1718–1729
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M et al (2006) Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 36:387–394
Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT (2007) Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 104:47–56
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405–412
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer Statistics, 2003. CA Cancer J Clin 53:5–26
Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824–842
Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479–1483
Madigan MP, Ziegler RG, Benichou J, Byrne C, Hooper RN (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87:1681–1685
Colditz GA, Frazier AL (1995) Models of breast cancer show that risk is set of events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4:567–571
Segaloff A, Maxfield WS (1971) The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res 31:166
Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin’s disease. J Natl Cancer Inst 85:25–31
Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, Provencio M, de Lafontan B, de la Rochefordiere A, Cellai E, Graic Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy J, Mignotte H, Velten M (2001) Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother Oncol 59:247–255
Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL (2001) Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys 49:539–546
Janov AJ, Tulecke M, O’Neill A, Lester S, Mauch PM, Harris J, Schnitt SJ, Shapiro CL (2001) Clinical and pathologic features of breast cancers in women treated for Hodgkin’s disease: a case-control study. Breast J 7:46–52
Lash TL, Aschengrau A (2000) Alcohol drinking and risk of breast cancer. Breast J 6:396–399
Spangler JG, Michielutte R, Bell RA, Dignan MB (2001) Association between smokeless tobacco use and breast cancer among Native-American women in North Carolina. Ethn Dis 11:36–43
Satcher D (2001) Women and health: a report of the Surgeon General - 2001. U.S. Dept. Health and Human Serv., PHS Office of the Surgeon General, 1–4
Russo IH, Tahin Q, Huang Y, Russo J (2001) Cellular and molecular changes induced by the chemical carcinogen benzo(a)pyrene in human breast epithelial cells and its association with smoking and breast cancer. J Women Cancer 3:29–36
Baron JA (2001) Breast cancer, hormone-related disorders and cigarette smoking. J Women Cancer 3:23–28
Phillips DH, Martin FL, Grover PL, Williams JA (2001) Toxicological basis for a possible association of breast cancer with smoking and other sources of environmental carcinogens. J Women Cancer 3:9–16
Ambrosone CB (2001) Impact of genetics on the relationship between smoking and breast cancer risk. J Women Cancer 3:17–22
Morabia A, Ambrosone CB, Baron JA, Phillips DH, Russo IH (2001) What do we currently know about the epidemiological and biologic plausibility of the association of smoking and breast cancer? J Women Cancer 3:5–8
Blot WJ, Fraumeni JF, Stone BJ (1977) Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 59:1407–1411
Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN (1995) Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 87:1846–1853
Nasca PC, Mahoney MC, Wolfgang PE (1992) Population density and cancer incidence differentials in New York State. Cancer Causes Control 3:7–15
Robbins AS, Brescianini S, Kelsey JL (1997) Regional differences in known risk factors and the higher incidence of breast cancer in San Francisco. J Natl Cancer Inst 89:960–965
Clarke CA, Glaser SL, West DW, Ereman RR, Erdmann CA, Barlow JM, Wrensch MR (2002) Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–1996. Breast Cancer Res 4:R13
Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure in solar radiation. Prev Med 19:614–622
Eisman JA, McIntyre I, Marti TJ, Frampton RJ, King RJ, King RJ (1980) Normal and malignant breast tissue is a target organ for 1,25-(OH)2 vitamin D3. Clin Endocrinol 13:267–272
Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19:820–824
National Council on Radiation Protection and Measurements (1987) Ionizing radiation exposures of the population of the United States. Rep. 93, Natl. Counc. Radiation. Prot. Meas., Washington, D.C.
McGregor DH, Land CE, Choi K, Tokuoka S, Liu PI, Wakabayashi I, Beebe GW (1977) Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki 1950–1989. J Natl Cancer Inst 59:799–811
Boice JD Jr, Preston D, Davis FG, Monson RR (1991) Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125:214–222
Boice JD Jr, Land CE, Preston DL (1996) Ionizing radiation. In: Scottenfeld DL, Fraumedni JF Jr (eds) Cancer epidemiology and prevention, 2nd edn. Oxford Univ. Press, New York, pp 319–372
National Academy Press (1990) Health effects of exposure to low levels of ionizing radiation (BIER V). National Academy Press, Washington, D.C., 421 pp
Brenner DJ, Sawant SG, Hande MP, Miller RC, Elliston CD, Fu Z, Randers-Pehrson G, Marino SA (2002) Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation? Int J Radiat Biol 78:1065–1067
U.S. Department of Energy (1996) Energy Information Administration. The changing structure of the Electric Power Industry; An Updata Rep. DOE/EIA-0562(96). U.S. Dept. Energy, Washington, D.C.
Stevens RG (1987) Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556–561
Tamarkin L, Baird CJ, Almeida OF (1985) Melatonin: a coordinating signal for mammalian reproduction? Science 227:714–720
Wurtman RJ, Axelrod J (1965) The pineal gland. Sci Am 213:50–60
Reiter RJ (1994) Melatonin suppression by static and extremely low frequency electromagnetic fields: relationship to the reported increased incidence of cancer. Rev Environ Health 10:171–186
Baum A, Mevissen M, Kamino K, Mohr U, Loscher W (1995) A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure. Carcinogenesis 16:119–125
Liburdy RP, Loscher W (1997) Laboratory studies on extremely low frequency (50/60-Hz) magnetic fields and carcinogenesis. In: Stevens RG, Wilson BW, Anderson LE (eds) The melatonin hypothesis, breast cancer and use of electric power. Batelle Press, Columbus, pp 585–668
Liburdy RP, Sloma TR, Sokolic R, Yaswen P (1993) ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin’s oncostatic action on ER + breast cancer cell proliferation. J Pineal Res 14:84–97
Loscher W, Mevissen M (1994) Mini-review: animal studies on the role of 50/60-Hertz magnetic fields in carcinogenesis. Life Sci 54:1531–1543
Wertheimer N, Leeper E (1987) Magnetic field exposure related to cancer subtypes. Ann NY Acad Sci 502:43–54
Florig HK, Hoburg JF (1990) Power-frequency magnetic fields from electric blankets. Health Phys 58:493–502
Preston-Martin S, Peters JM, Yu MC, Garabrant DH, Bowman JD (1988) Myelogenous leukemia and electric blanket use. Bioelectromagnetics 9:207–213
Vena JE, Freudenheim JL, Marshall R Jr, Laughlin R, Swanson M, Graham S (1994) Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol 140:974–979
Moysich KB, Ambrosone CB, Vena JE, Kostyniak P, Shields PG et al (1997) Serum polychlorinated biphenyls (PCBs) and postmenopausal breast cancer risk. Proc Am Assoc Cancer Res 38:627a
Kutz FW, Wood PH, Bottimore DP (1991) Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev Environ Contam Toxicol 120:1–82
Adami H-O, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A et al (1995) Organo-chlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551–566
Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A et al (1995) Organo-chlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25:463–531
Wolff MS, Collman GW, Barrett JC, Huff J (1996) Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 36:573–596
Bergthorsson JT, Ejlertsen B, Olsen JH, Borg A, Nielsen KV, Barkardottir RB, Klausen S, Mouridsen HT, Winther K, Fenger K, Niebuhr A, Harboe TL, Niebuhr E (2001) BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 38:361–368
Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res 61:4092–4097
Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC (2000) Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60:1062–1069
Kelsey JL, Horn-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15:7–16
MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–217
Vessey MD, McPherson K, Roberts MM, Neil A, Jones L (1985) Fertility and the risk of breast cancer. Br J Cancer 52:625–628
Trapido EJ (1983) Age at first birth, parity and breast cancer risk. Cancer 51:946–948
De Waard F, Trichopoulos D (1988) A unifying concept of the etiology of breast cancer. Int J Cancer 41:666–669
Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO (1996) Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38:305–311
Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K (1999) Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 75:122–129
Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494
Wurtman RJ (1984) Fall of nocturnal melatonin during puberty and prepubescence. Lancet 362:85
Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136
Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 44:4432–4436
Pillittere D, Miller M (2000) Researchers search for link between circadian rhythms, breast cancer. J Natl Cancer Inst 92:686–689
Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995) Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437–440
Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938–967
Rao GN, Piegorsch WW, Haseman JK (1987) Influence of body weight on the incidence of spontaneous tumors in rats and mice of long term studies. Am J Clin Nutr 45:252–260
Huggins C, Briziarelli G, Sutton H (1959) Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 709:25–42
Huggins C, Grand L, Fukunishi R (1964) Aromatic influences in the yields of mammary cancers following administration of 7,12-dimethylbenzanthracene. Proc Natl Acad Sci U S A 57:737–742
Gullino PM, Pettigrew HM, Grantham FH (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54:401–414
Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC et al (2001) Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22:2039–2047
Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P (2005) Tamoxifen inhibition of estrogen receptor-α–negative mouse mammary tumorigenesis. Cancer Res 65:3493–3496
Russo J, Russo IH (1987) Development of human mammary gland. In: Neville MC, Daniel C (eds) The mammary gland development, regulation and function. Plenum Publishing Corp, New York, pp 67–93
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:1–32
Russo J, Russo IH (eds) (2004) Molecular basis of breast cancer: prevention and treatment. Springer Verlag, Berlin
Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH et al (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103:1–8
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221
Hinkula M, Pukkala E, Kyyrönen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 12:491–500
Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12:R35
Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H et al (2010) Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 70:6779–6786
Mustacchi P (1961) Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med 108:639–642
Kroman N, Mouridsen HT (2003) Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 12:516–521
Kroman N, Melbye M, Mouridsen HT (2002) Prognostic influence of age at diagnosis in premenopausal breast cancer patients. Scand J Surg 91:305–308
Welsch CW (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45:3415–3443
Moral R, Wang R, Russo IH, Lamartiniere CA, Pereira J, Russo J (2008) Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol 196:101–112
Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M, Umekita Y, Yasuda N et al (2009) Effects of fetal exposure to diethylstilbestrol on mammary tumorigenesis in rats. J Vet Med Sci 71:1599–1608
Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H et al (2011) Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett 205:15–25
Goodman A, Schorge J, Greene MF (2011) The long-term effects of in utero exposures–the DES story. N Engl J Med 364:2083–2084
Russo IH, Russo J (2007) Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res 174:111–130
Russo J, Tait L, Russo IH (1983) Susceptibility of the mammary gland to carcinogenesis: III the cell of origin of rat mammary carcinoma. Am J Pathol 113:50–66
Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R et al (2006) The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11:151–172
Bennett DC, Peachey LA, Durbin H, Rudland PS (1978) A possible mammary stem cell line. Cell 15:283–298
Bussard KM, Smith GH (2011) The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol. doi:10.1155/2011/451676
Hernandez-Gonzalez M, Juarez J (2000) Alcohol before puberty produces an advance in the onset of sexual behavior in male rats. Alcohol 21(2):133–140
Harris C (2001) Tobacco smoking and cancer risk in women. J Women Cancer 3:1–4
Russo J, Barnabas N, Higgy N, Salicioni AM, Wu YL, Russo IH (1996) Molecular basis of human breast cell transformation. In: Calvo F, Crepin M, Magdelenat H (eds) Advances in breast cancer research. Eurotext, Paris, pp 33–43
Stevens RG, Davis S, Mirick DK, Kheifets L, Kaune W (2000) Alcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy women. Epidemiology 11(6):660–665
Falcon J (1999) Cellular circadian clocks in the pineal [Review]. Prog Neurobiol 58:121–162
Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii:104
Jordan VC (1976) Effect of tamoxifen (ICI 46,474) on the initiation and growth of DMBA-induced rat mammary carcinoma. Eur J Cancer 12:419–424
Russo IH, Koszalka M, Gimotty PA, Russo J (1990) Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 62:243–247
Russo IH, Koszalka M, Russo J (1991) Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 64:481–484
Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE et al (2006) Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66:6421–6431
Medina D, Kittrell FS (2003) p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63:6140–6143
Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D (2007) Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9:R12
Weroha SJ, Li SA, Tawfik O, Li JJ (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27:491–498
Li SA, Weroha SJ, Tawfik O, Li JJ (2002) Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen r eceptor mediation. J Endocrinol 175:297–305
Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006) 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20:1622–1634
Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Afanasyeva Y et al (2010) Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control 21:719–727
Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H et al (2011) Circulating estrogens and progesterone during primiparous. pregnancies and risk of maternal breast cancer. Int J Cancer 130:910–920
Russo IH, Gimotty P, Dupuis M, Russo J (1989) Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis. Br J Cancer 59:210–216
Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC et al (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333–350
Russo J, Rivera R, Russo IH (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23:211–218
Lathi RB, Fisher SJ, Giudice LC (2006) Implantation and placental physiology in early human pregnancy: the role of the maternal decidua and the trophoblast. In: De Groot L, Jameson LJ (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3341–3351
Parry S, Strauss F III (2006) Placental hormones. In: De Groot L, Jameson LJ (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 3353–3367
Alvarado MV, Ho T-Y, Russo J, Russo IH (1994) Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and the mammary gland of rats. Endocrine 2:1–10
Alvarado ME, Alvarado NE, Russo J, Russo IH (1994) Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro 30A:4–8
Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S et al (2003) Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88:914–919
Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG et al (2011) Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control 20, e2
Johansson AL, Andersson TM, Hsieh CC, Cnattingius S, Lambe M (2011) Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomarkers Prev 20:1865–1872
Hahn RA, Moolgavkar SH (1989) Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health 79:1503–1507
Mathews TJ, Hamilton BE (2009) Delayed childbearing: more women are having their first child later in life. National Center for Health Statistics data brief No. 21, Hyattsville, MD
Lakshmanaswamy R, Guzman RC, Nandi S (2008) Hormonal prevention of breast cancer: significance of promotional environment. Adv Exp Med Biol 617:469–475
Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH et al (2006) Genomic signature induced by pregnancy in the human breast. Int J Oncol 28:399–410
Russo J, Balogh GA, Russo IH (2008) Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51–66
George K, Kamath MS (2010) Fertility and age. J Hum Reprod Sci 3:121–123
Homan GF, Davies M, Norman R (2007) The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment. Hum Reprod Update 13:209–223
Downs JL, Wise PM (2009) The role of the brain in female reproductive aging. Mol Cell Endocrinol 299:32–38
Russo IH, Medado J, Russo J (1989) Endocrine influences on mammary gland structure and development. In: Jones TC, Mohr U, Hunt RD (eds) Integument and mammary gland of laboratory animals. Springer Verlag, Berlin, pp 252–266
Gleicher N, Weghofer A, Barad DH (2011) Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 9:23
Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB et al (1998) Dimeric inhibin: a direct marker of ovarian ageing. Fertil Steril 70:119–123
Rance NE (2009) Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 30:111–122
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Russo, J. (2016). The Windows of Susceptibility to Breast Cancer. In: The Pathobiology of Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-40815-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-40815-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40813-2
Online ISBN: 978-3-319-40815-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)